CALR and ovarian carcinoma: As an approach to investigate CRT expression and release from ovarian cancer cells under ER stress conditions, OVcar3 cells were treated with DX (0.125–2.5 μM), TG (0.2 μM) for 16 h ± 200 μM TUDCA.